In addition to the new research presented, Mintu Turakhia, MD, MAS, iRhythm Chief Medical and Scientific Officer and EVP, Product Innovation, and HRX Founding Co-Chair in 2021, also participated ...
So if this idea of high risk and high reward doesn't suit, you might be more interested in profitable, growing companies, like Héroux-Devtek (TSE:HRX). While profit isn't the sole metric that ...
HRX, an initiative pioneered by the Heart Rhythm Society (HRS), is focused on exploring digital technologies that advance the boundaries of innovation in cardiovascular medicine. Stereotaxis CEO ...
Results that may be inaccessible to you are currently showing.